AVR

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Dollar change -0.16
Percentage change -3.11	%

Held by: IWN IWO VTWO IWC RSSL VTWV VTWG UWM URTY ITWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.12	Insider Own	0.18%	Shs Outstand	36.02M	Perf Week	73.22%
Market Cap	179.38M	Forward P/E	-	EPS next Y	-1.83	Insider Trans	0.00%	Shs Float	35.96M	Perf Month	6.87%
Income	-76.29M	PEG	-	EPS next Q	-0.47	Inst Own	48.24%	Short Float	1.43%	Perf Quarter	-16.86%
Sales	2.70M	P/S	66.44	EPS this Y	41.51%	Inst Trans	36.93%	Short Ratio	2.25	Perf Half Y	-
Book/sh	1.75	P/B	2.85	EPS next Y	3.01%	ROA	-137.18%	Short Interest	0.52M	Perf Year	-
Cash/sh	1.96	P/C	2.55	EPS next 5Y	19.74%	ROE	-185.94%	52W Range	2.34 - 8.79	Perf YTD	-10.75%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-120.32%	52W High	-43.34%	Beta	-
Dividend TTM	-	Quick Ratio	4.48	Sales past 5Y	-7.86%	Gross Margin	-8.92%	52W Low	112.82%	ATR (14)	0.56
Dividend Ex-Date	-	Current Ratio	4.51	EPS Y/Y TTM	-65.77%	Oper. Margin	-2899.45%	RSI (14)	59.28	Volatility	15.77% 16.63%
Employees	136	Debt/Eq	0.02	Sales Y/Y TTM	-1.16%	Profit Margin	-2822.46%	Recom	1.00	Target Price	14.67
Option/Short	No / Yes	LT Debt/Eq	0.01	EPS Q/Q	-36.58%	Payout	-	Rel Volume	0.96	Prev Close	5.14
Sales Surprise	-18.18%	EPS Surprise	-7.96%	Sales Q/Q	-1.48%	Earnings	Feb 26	Avg Volume	229.17K	Price	4.98
SMA20	46.85%	SMA50	-9.66%	SMA200	-12.68%	Trades		Volume	219,359	Change	-3.11%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-08-25	Initiated	Lake Street	Buy	$20
Jan-07-25	Initiated	TD Cowen	Buy	$15
Jan-07-25	Initiated	Cantor Fitzgerald	Overweight	$9
Jan-07-25	Initiated	Barclays	Overweight	$22

Mar-31-25 07:15AM	Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR THV (GlobeNewswire)
Mar-21-25 07:30AM	Anteris Reports One-Year Patient Outcomes for DurAVR THV (GlobeNewswire) -10.16%
Mar-12-25 08:33PM	Anteris Reports 2024 Financial Results and Provides Corporate Update (GlobeNewswire) -6.18%
Feb-28-25 08:00AM	Anteris to Present at Healthcare Investor Conferences - TD Cowen and Barclays (GlobeNewswire)
Dec-16-24 07:49PM	Anteris Technologies Global Corp. Announces Closing of $88.8 Million U.S. Initial Public Offering (Business Wire)
10:34PM	Loading…
Dec-12-24 10:34PM	Anteris Technologies Global Corp. Announces Pricing of U.S. Initial Public Offering (Business Wire)

Anteris Technologies Global Corp. is a structural heart company, which engages in the development and commercialization of medical devices for heart diseases. It operates through the following geographical segments: United States, Germany, Australia, Switzerland, and Sweden. The company was founded in 1999 and is headquartered in Eagan, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Seaberg John D	Director	Mar 06 '25	Option Exercise	7.13	40,000	285,200	40,000	Mar 20 07:43 PM
Paterson Wayne	Chief Executive Officer	Mar 05 '25	Option Exercise	7.13	233,000	1,661,290	233,000	Mar 20 07:40 PM
Denaro Stephen	Director	Mar 11 '25	Option Exercise	7.13	16,500	117,645	23,722	Mar 20 07:35 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Anteris Technologies Global Corp

Upgrade your FINVIZ experience